Repligen Corp

Common Name
Repligen
Country
United States
Sector
Healthcare
Industry
Medical Instruments & Supplies
Employees
1,778
Ticker
RGEN
Exchange
NASDAQ/NGS
Description
Repligen Corporation is a leading global provider of bioprocessing technologies and solutions that support the development and manufacture of biologic drugs. Specializing in high-value consumable prod...

Repligen's GHG Emissions Data Preview

In 2023, Repligen completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources), Scope 2 (indirect emissions from purchased energy) and Scope 3 (indirect emissions across the value chain).

Repligen has also provided a category-level breakdown for 1 out of 15 Scope 3 emissions categories, offering greater transparency into its value chain emissions.

Metric (tCO2e)2023202220212020 - 2017
Total Scope 1
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
a
0000000
Total Scope 2
Market-Based
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
a
0000000
Location-Based
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
0000000
Total Scope 3
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
0000000
Total Scope 1 Revenue Intensity (tCO2e/$M)
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
a
0000000
Download Data

Verified Sources Behind Repligen’s Greenhouse Gas (GHG) Emissions Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Repligen’s data sources below and access millions more through our Disclosure Search.

a. Repligen's Sustainability Report 2023
a. Repligen's Sustainability Report 2023

Insights into Repligen's Operational Emissions

In 2023, the total operational greenhouse gas (GHG) emissions of Repligen amounted to 12,017 metric tons of CO2 equivalent. This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2). a

Compared to 2022, the total operational greenhouse gas (GHG) emissions of Repligen increased by 181.49%, suggesting that the company faced challenges in reducing its emissions from its core operations. a

Repligen's Scope 1 Emissions Over Time

2019202020212022202306001.2 k1.8 k2.4 ktCO2e+16%+38%+61%+69%
  • Total Scope 1
  • Year-over-Year Change

What are Repligen's Scope 1 emissions?

In 2023, the total Scope 1 emissions of Repligen were 2,236 metric tons of CO₂ equivalent (tCO₂e). a

Has Repligen reduced its Scope 1 emissions over time?

Since 2019, Repligen's Scope 1 emissions have increased by 332.5%, reflecting a rising long-term trend in Scope 1 emissions over time. a

Compared to the previous year (2022), Repligen's Scope 1 emissions increased by 69.14%, suggesting that the company faced challenges in reducing emissions from its directly owned or controlled operations. a

What are Repligen's Scope 2 emissions?

In 2023, Repligen reported Scope 2 greenhouse gas (GHG) emissions of 959 tCO₂e using the market-based method and 9,781 tCO₂e using the location-based method. a

What methodology does Repligen use for Scope 2 reporting?

In 2023, Repligen reported its Scope 2 emissions using the market-based method and using the location-based method. a

Repligen's Scope 2 Emissions Over Time

2019202020212022202302.5 k5 k7.5 k10 ktCO2e
  • Total Scope 2 Location-Based
  • Total Scope 2 Market-Based

Insights into Repligen's Value Chain Emissions

In 2023, Repligen reported 14,940 metric tons of CO₂ equivalent (tCO₂e) of Scope 3 greenhouse gas (GHG) emissions, representing indirect emissions across its upstream and downstream value chain. a

The 2023 disclosure of Repligen includes a breakdown across 1 of the 15 Scope 3 categories defined by the GHG Protocol, up from 0 in 2022, reflecting improved emissions accounting practices and greater transparency across the company's value chain a

Repligen's Scope 3 Emissions Over Time

2022202304 k8 k12 k16 ktCO2e+23%
  • Total Scope 3
  • Year-over-Year Change

What are Repligen's Scope 3 emissions?

In 2023, Repligen reported total Scope 3 emissions of 14,940 metric tons of CO₂ equivalent (tCO₂e). a

Approximately 100% of these emissions originated from upstream activities such as purchased goods and capital goods, while 0% came from downstream activities like product use, distribution, and end-of-life treatment. a

Compared to the previous year (2022), Repligen's Scope 3 emissions increased by 23.39%, suggesting that the company faced challenges in reducing emissions across its value chain. a

What categories of Scope 3 emissions does Repligen disclose?

In 2023, Repligen reported emissions for 1 out of the 15 Scope 3 categories defined by the GHG Protocol. a

The limited disclosure restricts visibility into specific emission sources across the company's value chain.

What are the main sources of Repligen's Scope 3 emissions?

In 2023, the largest contributors to Repligen's Scope 3 emissions were: a

  • Fuel- and Energy-Related Services (Cat. 3): 773 tCO₂e (100%)

Repligen's Scope 3 Emissions by Categories

Fuel- andEnergy-RelatedServices (Cat. 3)(100.0%)

Insights into Repligen’s GHG Emissions Intensity Compared to Industry Peers

In 2023, Repligen reported Scope 1 greenhouse gas (GHG) emissions of 2,236 tCO₂e and total revenues of USD 632 millions. This translates into an emissions intensity of 3.54 tCO₂e per millions USD. a

Repligen's Scope 1 Emissions Intensity Compared to Peers

51002,00050,0001,000,000Scope 1 Emissions (tCO2e)1005002,00010,00050,000Revenues (Millions of USD)TAzentaYear: 2023Scope 1: 14,399 tCO2eRevenue: $M 665Scope 1 Intensity: 21.65 tCO2e/$MResmedYear: 2023Scope 1: 4,453 tCO2eRevenue: $M 4,223Scope 1 Intensity: 1.05 tCO2e/$MVeracyteYear: 2023Scope 1: 448 tCO2eRevenue: $M 361Scope 1 Intensity: 1.24 tCO2e/$MInsmedYear: 2024Scope 1: 1,666 tCO2eRevenue: $M 364Scope 1 Intensity: 4.58 tCO2e/$MAptargroupYear: 2023Scope 1: 24,660 tCO2eRevenue: $M 3,487Scope 1 Intensity: 7.07 tCO2e/$MAvantorYear: 2023Scope 1: 26,095 tCO2eRevenue: $M 6,967Scope 1 Intensity: 3.75 tCO2e/$MFrontage HoldingsYear: 2023Scope 1: 2,883 tCO2eRevenue: $M 2,027Scope 1 Intensity: 1.42 tCO2e/$MBecton Dickinson and CoYear: 2023Scope 1: 162,475 tCO2eRevenue: $M 19,372Scope 1 Intensity: 8.39 tCO2e/$MWest Pharmaceutical ServicesYear: 2024Scope 1: 31,327 tCO2eRevenue: $M 2,893Scope 1 Intensity: 10.83 tCO2e/$MCooper CompaniesYear: 2024Scope 1: 58,155 tCO2eRevenue: $M 3,895Scope 1 Intensity: 14.93 tCO2e/$MGlaukosYear: 2024Scope 1: 523 tCO2eRevenue: $M 383Scope 1 Intensity: 1.36 tCO2e/$MWarby ParkerYear: 2023Scope 1: 961 tCO2eRevenue: $M 670Scope 1 Intensity: 1.43 tCO2e/$MBaxter InternationalYear: 2024Scope 1: 324,000 tCO2eRevenue: $M 10,636Scope 1 Intensity: 30.46 tCO2e/$MDENTSPLY SIRONAYear: 2024Scope 1: 4,705 tCO2eRevenue: $M 3,793Scope 1 Intensity: 1.24 tCO2e/$MTeleflexYear: 2024Scope 1: 16,256 tCO2eRevenue: $M 3,047Scope 1 Intensity: 5.33 tCO2e/$MMerit Medical SystemsYear: 2023Scope 1: 3,072 tCO2eRevenue: $M 1,257Scope 1 Intensity: 2.44 tCO2e/$MCertaraYear: 2023Scope 1: 363 tCO2eRevenue: $M 354Scope 1 Intensity: 1.03 tCO2e/$MAlignment HealthcareYear: 2023Scope 1: 131 tCO2eRevenue: $M 1,824Scope 1 Intensity: 0.07 tCO2e/$MTTTwist BioscienceYear: 2024Scope 1: 7 tCO2eRevenue: $M 313Scope 1 Intensity: 0.02 tCO2e/$MEnvista HoldingsYear: 2024Scope 1: 3,000 tCO2eRevenue: $M 2,511Scope 1 Intensity: 1.19 tCO2e/$MIntuitive SurgicalYear: 2024Scope 1: 8,105 tCO2eRevenue: $M 8,352Scope 1 Intensity: 0.97 tCO2e/$MIonis PharmaceuticalsYear: 2024Scope 1: 2,616 tCO2eRevenue: $M 705Scope 1 Intensity: 3.71 tCO2e/$MHologicYear: 2024Scope 1: 7,050 tCO2eRevenue: $M 4,030Scope 1 Intensity: 1.75 tCO2e/$MNateraYear: 2024Scope 1: 5,143 tCO2eRevenue: $M 1,697Scope 1 Intensity: 3.03 tCO2e/$MRepligenYear: 2023Scope 1: 2,236 tCO2eRevenue: $M 632Scope 1 Intensity: 3.54 tCO2e/$M

How does Repligen's GHG emissions intensity compare to its peers?

In 2023, Repligen reported a Scope 1 emissions intensity of 3.54 tCO₂e per millions USD. Compared to the peer group median of 2.1 , this places the company above its industry benchmark, indicating it is less carbon-efficient than most competitors. a

Where does Repligen rank on GHG emissions intensity within its industry?

In 2023, Repligen ranked 15 out of 24 companies in its industry peer group, based on Scope 1 emissions intensity (measured in tCO₂e per millions USD). a

Repligen is therefore positioned in the mid-range of its industry, neither a clear leader nor a laggard in carbon efficiency. a

Insights into Repligen's Total Carbon Footprint

In 2023, Repligen reported a total carbon footprint of 26,957 metric tons of CO₂ equivalent (tCO₂e) across Scope 1, Scope 2, and Scope 3 emissions. This represents a 64.6% increase compared to 2022, suggesting a rise in emissions across its operations or value chain. a

The largest contributor to Repligen's total carbon footprint was Scope 3 emissions, accounting for 55.42% of the company's total carbon footprint, followed by Scope 2 emissions at 36.28%. a

Want Full Access to Repligen's GHG Emissions Dataset?
Sign Up